BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29374493)

  • 1. Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.
    Xu Y; Yu X; Wei C; Nie F; Huang M; Sun M
    J Exp Clin Cancer Res; 2018 Jan; 37(1):13. PubMed ID: 29374493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
    Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.
    Liu Z; Chen Z; Fan R; Jiang B; Chen X; Chen Q; Nie F; Lu K; Sun M
    Mol Cancer; 2017 Apr; 16(1):82. PubMed ID: 28441948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
    Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
    Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pseudogene derived from long non-coding RNA DUXAP10 promotes colorectal cancer cell growth through epigenetically silencing of p21 and PTEN.
    Lian Y; Xu Y; Xiao C; Xia R; Gong H; Yang P; Chen T; Wu D; Cai Z; Zhang J; Wang K
    Sci Rep; 2017 Aug; 7(1):7312. PubMed ID: 28779166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA DUXAP10 exerts oncogenic properties in osteosarcoma by recruiting HuR to enhance SOX18 mRNA stability.
    Wang G; Zhang Q; Wang Q; Wang J; Chen L; Sun Q; Miao D
    Hum Cell; 2022 Nov; 35(6):1939-1951. PubMed ID: 36053455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.
    Xu Y; Yu X; Wei C; Nie F; Huang M; Sun M
    J Exp Clin Cancer Res; 2023 Sep; 42(1):233. PubMed ID: 37674173
    [No Abstract]   [Full Text] [Related]  

  • 10. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer.
    Lian Y; Xiao C; Yan C; Chen D; Huang Q; Fan Y; Li Z; Xu H
    J Cell Biochem; 2018 Apr; 119(4):3671-3682. PubMed ID: 29286182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STRA6 exerts oncogenic role in gastric tumorigenesis by acting as a crucial target of miR-873.
    Lin L; Xiao J; Shi L; Chen W; Ge Y; Jiang M; Li Z; Fan H; Yang L; Xu Z
    J Exp Clin Cancer Res; 2019 Nov; 38(1):452. PubMed ID: 31694721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.
    Huang M; Hou J; Wang Y; Xie M; Wei C; Nie F; Wang Z; Sun M
    Mol Ther; 2017 Apr; 25(4):1014-1026. PubMed ID: 28214253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VRK1 promotes proliferation, migration, and invasion of gastric carcinoma cells by activating β-catenin.
    Wang L; Zhai R; Shen H; Song G; Wan F; Li Q
    Neoplasma; 2021 Sep; 68(5):1005-1014. PubMed ID: 34374295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer.
    Zheng L; Kang L; Cheng Y; Cao J; Liu L; Xu H; Gao L
    Pathol Oncol Res; 2021; 27():581542. PubMed ID: 34385891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
    Dai XM; Zhang YH; Lin XH; Huang XX; Zhang Y; Xue CR; Chen WN; Ye JX; Lin XJ; Lin X
    Mol Oncol; 2021 Jan; 15(1):228-245. PubMed ID: 33128264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.
    Liu WG; Xu Q
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7905-7912. PubMed ID: 31599413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition.
    Ma X; Chen H; Li L; Yang F; Wu C; Tao K
    J Exp Clin Cancer Res; 2021 Oct; 40(1):330. PubMed ID: 34666800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.